CAS: 622-33-3; O-Benzylhydroxylamine

该化合物是一种多用途有机化合物,广泛用作合成化学的试剂,其主要优点包括它作为氢氧胺的保护群体的作用及其在形成氧化氮衍生物中的效用.苯基组增强了稳定性,适合各种条件下的反应.该组在peptide合成和编制三环化合物方面特别有用.该组在常见有机溶剂中表现出良好的溶性,便于其用于多种反应装置.该组与碳基化合物的再活动作用进一步突出了其在有机合成和制药应用中的重要性.

结构式图片

欧盟法规

C&L通报REACH预注册

上下游产品

CAS号16653-19-3 N-(苄氧基)邻苯二甲酰亚胺 | CAS号2687-43-6 苄氧基胺盐酸盐 | CAS号100-51-6 苯甲醇 | CAS号100-44-7 氯化苄 | CAS号100-39-0 溴化苄 | CAS号67-62-9 O-甲基羟胺 | CAS号100-63-0 苯肼 | CAS号497-25-6 2-恶唑烷酮 | CAS号3532-25-0 N-phenylmethoxy... | CAS号115364-82-4 [1-[(benzyloxy)... | CAS号100-46-9 苄胺 | CAS号2048-52-4 4-amino-1-pheny... | CAS号22426-89-7 4-methoxy-N-phe... | CAS号106-40-1 对溴苯胺 | CAS号140-11-4 乙酸苄酯 | CAS号103-50-4 二苄醚 | CAS号100-51-6 苯甲醇

合成工艺路线路线简述

    N-苯基甲氧基氨基甲酸乙酯置于氢氧化钾体系中,用 甲醇 作为反应溶剂,化学反应生成 O-苄基羟胺
    参考文献:O,N-取代羟基胺.2. Mitteilung.o-(苯基烷基)-羟胺的合成与本征交换(untersuchungenübersynthetische Arzneimitteln Ii)
    标题:O,N-取代羟基胺.2. Mitteilung.o-(苯基烷基)-羟胺的合成与本征交换(untersuchungenübersynthetische Arzneimitteln Ii)
    摘要:Es Wirdüber合成,化学与物理化学化学反应,合成o-(苯基烷基)-羟胺胺.盐酸氢硼酸甘油酯,位于羟基苯并二苯并二恶英,C-Atome得到了保护,氢已被氨化,氨氮磷铵.letztere Wurden Zum Teil气相色谱法和鉴定方法.分子式:A-(1-甲基-2-苯基-乙基)-羟基lamin-盐酸盐:氯化铵,丙苯酮(72%)和甲基苄基酮(28%).o-(2-苯基-乙基)-羟基lamin-盐酸盐:氯化铵和2,5-二苯基-1,4-二恶烷;o-(1-甲基-2-苯基-乙基)-N-甲基-羟基lamin-盐酸盐:甲胺盐酸盐,丙炔酮(59.4%)和甲基-苄基酮(40.6%);
    DOI:10.1002/hlca.19620450502

    海关参考信息

    专利信息


    专利号:US-5977301-A
    优先权日:1992-09-24
    标题 :Synthesis of N-substituted oligomers
    发明人:ZUCKERMAN RONALD N; KERR JANICE M; KENT STEPHEN B H; MOOS WALTER H; SIMON REYNA J; GOFF DANE A
    权利人:CHIRON CORP
    摘要:A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.

    专利号:EP-0671928-B1
    优先权日:1992-09-24
    标题 :Synthesis of n-substituted oligomers
    发明人:ZUCKERMANN RONALD N; KERR JANICE M; KENT STEPHEN BRIAN HENRY; MOOS WALTER H; SIMON REYNA J; GOFF DANE A
    权利人:CHIRON CORP
    摘要:Poly N-substituted Glycines (poly NSGs), wherein the substituents bear purine or pyrimidine bases (R<9>) every second glycine: In addition, a solid phase method for the synthesis of N-substituted oligomers of more general structures is disclosed.The poly NSGs obtainable by this method can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using the automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.

    专利号:US-5877278-A
    优先权日:1992-09-24
    标题:Synthesis of N-substituted oligomers
    发明人:ZUCKERMANN RONALD N; GOFF DANE A; NG SIMON; SPEAR KERRY; SCOTT BARBARA O; SIGMUND AARON C; GOLDSMITH RICHARD A; MARLOWE CHARLES K; PEI YAZHONG; RICHTER LUTZ; SIMON REYNA
    权利人:CHIRON CORP
    摘要:A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a solid support-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability. Combinatorial libraries of cyclic compounds are disclosed wherein the cyclic compounds are comprised of at least one ring structure derived from cyclization of a peptoid backbone. The diversity of product compounds is generated by the sequential addition of substituted submonomers. The combinatorial library includes 10 or more, preferably 100 or more, and more preferably 1,000 or more distinct and different compounds. The library includes each of the product compounds in retrievable and analyzable amounts and preferably includes at least one biologically active compound. Methods of synthesizing the combinatorial libraries and assay devices produced using the libraries are disclosed as is methodology for screening for and obtaining biologically active cyclic organic compounds.

    专利号:US-6063919-A
    优先权日:1998-08-14
    标题:Process for the synthesis of exochelins
    发明人:GAUDIOSO LARRY A; WEGLARZ MICHAEL A
    权利人:KEYSTONE BIOMEDICAL INC
    摘要:A process for the synthesis of an Exochelin comprising the steps of generating L-N-[(2-benzyloxy-(benzoyl)] serine or L-N-[2-benzyloxy (benzoyl)] threonine, creating L-N-t-Boc- epsilon -hydroxynorleucine and reacting same to produce L-N-Boc- epsilon -bromonorleucine trimethylsilylethyl ester, providing a dicarboxylic acid and forming an O-benzyl methyl hydroxamate from the dicarboxylic acid, coupling the O-benzyl methyl hydroxamate with the L-N-Boc- epsilon -bromonorleucine trimethylsilylethyl ester to give an L-N2-Boc-N6-methyl,N6-(benzyloxy) lysine 2-trimethylsilylethyl ester which incorporates the dicarboxylic acid as modified above, removing the N-tert-butoxycarbonyl protecting group from the L-N2-Boc-N6-methyl, N6-(benzyloxy) lysine 2-trimethylsilylethyl ester to yield a substituted lysine, and coupling the same with the L-N-[2-benzyloxy (benzoyl) serine or -threonine to yield a 2-trimethyl silylethyl ester of dibenzyl Exochelic acid, transforming the 2-trimethyl silylethyl ester of dibenzyl Exochelic acid to dibenzyl Exochelic acid, preparing benzyl epi-cobactin, forming an ester bond between the dibenzyl Exochelic acid and benzyl epi-cobactin to form an intermediate, and, hydrogenolytically removing three benzyl groups from said intermediate, resulting in the synthesized Exochelin. More particularly, a synthesis for Exochelin 786SM (R) is disclosed wherein the dicarboxylic acid is suberic acid and the serine form is utilized.

    专利号:US-7102023-B2
    优先权日:1999-11-24
    标 题:Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries
    发明人:BUCHWALD STEPHEN L; PLANTE OBADIAH J; SEEBERGER PETER H
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:One aspect of the present invention relates to optionally substituted halogenated benzyl halides and the like. These compounds are useful as halogenated benzyl ether-based protecting groups for a variety of functional groups. Another aspect of the present invention relates to use of said protecting groups in an orthogonal protecting group strategy for the synthesis of complex molecules that comprise a number of suitable functional groups. Another aspect of the present invention relates to saccharides bearing various arrays of protecting groups of the present invention. Another aspect of the present invention relates to a method of synthesizing an oligosaccharide or glycoconjugate, comprising the steps of: using a saccharide bearing at least one protecting group of the present invention to glycosylate a second molecule to give a product comprising said saccharide; and removing a protecting group of the present invention from said product.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
    北京偶合科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ouhechem.com
    企业联系电话:010-51280831(不占线);010-82967028👤
    📞北京偶合科技有限公司 ⚠️参考联系方式
    联系人:刘先生
    电话:010-51280831(不占线);010-82967028
    手机:13911808554
    传真:010-82967029
    邮箱:sales@ouhechem.com
    通信地址: 北京市海淀区西三旗桥东上奥世纪2b-1328室
    邮编: 100096
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三旗桥东上奥世纪2b-1328室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    郑州今斯孚化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.kingsfine.com/index.html
    电话: 0371-56632527 13838252817👤
    📞郑州今斯孚化学有限公司 ⚠️参考联系方式

    销售电话:0371-56632527 13838252817
    邮箱:sales@kingsfine.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1107/s1600536811019015
    摘要:Wang H, He LJ, Zheng WH, Song HC. 3-[(E)-1-(Benzyl-oxyimino)-eth-yl]-7-(3-methyl-but-2-en-yloxy)-2H-chromen-2-one. Acta Crystallogr Sect E Struct Rep Online. 2011 Jun 01;67(Pt 6):o1516.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知